Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection
Clinical trial NCT01905410 · COMPLETED
Trial details
- NCT number
- NCT01905410
- Sponsor
- Vivozon, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-03-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.